• Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • Jul 19 2022
  • Duración: 10 m
  • Podcast

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma  Por  arte de portada

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • Resumen

  • Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

    Read the full article:
    Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.